
201 - 500 employees
Founded 1992
🧬 Biotechnology
💊 Pharmaceuticals
💰 $250M Post-IPO Debt - Geron on 2024-11
Biotechnology • Pharmaceuticals
Geron is a biotechnology company focused on developing medicines that inhibit telomerase to treat myeloid hematologic malignancies and other blood cancers. The company conducts research and development and clinical trials, reports an R&D pipeline and patient-focused programs, and notes that it has a medicine approved for use in the United States. Geron emphasizes a mission to extend and enhance patients' lives, corporate governance, and equal employment practices.
🕒 July 7
Oncology Key Account Manager responsible for account management and relationship building with prescribers. Driving market share growth in the San Francisco Bay Area and surrounding regions.
🏄 California – Remote
💵 $195k - $205k / year
💰 $250M Post-IPO Debt - Geron on 2024-11
⏰ Full Time
🟠 Senior
🔴 Lead
💰 Account Manager
🕒 June 27
Oncology Key Account Manager engaging with academic centers and hospitals in Indiana and lower Michigan. Establishing relationships and driving market share growth in the oncology sector.
🚗 Michigan – Remote
💵 $195k - $205k / year
💰 $250M Post-IPO Debt - Geron on 2024-11
⏰ Full Time
🟠 Senior
🔴 Lead
💰 Account Manager
🕒 June 26
Regional Medical Scientific Director serves as a trusted partner to enhance medical education and generate data insights. Role involves maintaining scientific relationships within the territory.
🌲 North Carolina, South Carolina – Remote
💵 $230k - $245k / year
💰 $250M Post-IPO Debt - Geron on 2024-11
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
🕒 June 25
Oncology Key Account Manager serving as the lead point of contact for account management activities. Focused on generating and expanding market share within the designated territory.
🤠 Texas – Remote
💵 $195k - $205k / year
💰 $250M Post-IPO Debt - Geron on 2024-11
⏰ Full Time
🟠 Senior
🔴 Lead
💰 Account Manager